Corey McCann is President and CEO of Pear Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 23 | PEARQ Pear Therapeutics | RSU Class A Common Stock | Grant | Acquire A | No | No | 0 | 2,857,142 | 0.00 | 2,857,142 |
20 Jan 23 | PEARQ Pear Therapeutics | Class A Common Stock | Sell | Dispose S | No | No | 1.13 | 34,731 | 39.25 k | 8,210,834 |
14 Jan 23 | PEARQ Pear Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 88,000 | 0.00 | 8,245,565 |
14 Jan 23 | PEARQ Pear Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 88,000 | 0.00 | 178,667 |